Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Antimicrobial therapy utilization in neonates with hypoxic-ischemic encephalopathy (HIE): a report from the Children’s Hospital Neonatal Database (CHND)

Abstract

Objective(s)

Quantify antimicrobial therapy (AMT) use in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia (HIE/TH).

Study design

Newborns with HIE/TH were identified from the Children’s Hospital Neonatal Database (CHND). Early infection (onset ≤7 days of life) was defined as “confirmed” (culture proven) or “suspected infection” (culture negative but treated) and compared with a “no infection” group.

Results

1501/1534 (97.8%) neonates received AMT. 36 (2.3%) had confirmed, 255 (16.6%) suspected, and 1243 (81.0%) had no infection. The median (IQR) AMT duration was 13 (8–21), 8 (7–10), and 3 (3–7) days for the three groups, respectively (p < 0.001). AMT duration of use varied significantly across centers, adjusted for covariates (OR 1.88, 95% CI: 1.43–2.46).

Conclusion(s)

Incidence of early confirmed infection in neonates with HIE/TH (23/1000) is significantly higher than reported rates of early onset sepsis in term and near term infants (0.5–1.0/1000 live births). Antimicrobial-stewardship opportunities exist in infants with negative cultures.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy. Early Hum Dev 2010;86:329–38.

    PubMed  Google Scholar 

  2. Gluckman PD, Gunn AJ, Wyatt JS. Hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2006;354:1643–5.

    PubMed  Google Scholar 

  3. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366:2085–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD003311.pub3.

  5. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O’Sullivan F, Burton PR, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. Br Med J. 1998;317:1549–53.

    CAS  Google Scholar 

  6. Martinez-Biarge M, Diez-Sebastian J, Wusthoff CJ, Mercuri E, Cowan FM. Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy. Pediatrics. 2013;132:e952–9.

    PubMed  Google Scholar 

  7. Zhao J, Chen Y, Xu Y, Pi G. Effect of intrauterine infection on brain development and injury. Int J Dev Neurosci. 2013;31:543–9.

    PubMed  Google Scholar 

  8. Yuan T-M, Sun Y, Zhan C-Y, Yu H-M. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling. J Neuroimmunol. 2010;229:16–25.

    CAS  PubMed  Google Scholar 

  9. Lindberg TP, Caimano MJ, Hagadorn JI, Bennett EM, Maas K, Brownell EA, et al. Preterm infant gut microbial patterns related to the development of necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2018:1–231. https://doi.org/10.1080/14767058.2018.1490719.

    Google Scholar 

  10. Gibson MK, Crofts TS, Dantas G. Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol. 2015;27:51–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Lu J, Lu L, Yu Y, Cluette-Brown J, Martin CR, Claud EC. Effects of intestinal microbiota on brain development in humanized gnotobiotic mice. Sci Rep. 2018;8:5443.

    PubMed  PubMed Central  Google Scholar 

  12. Murthy K, Dykes FD, Padula MA, Pallotto EK, Reber KM, Durand DJ, et al. The Children’s Hospitals Neonatal Database: an overview of patient complexity, outcomes and variation in care. J Perinatol. 2014;34:582–6.

    CAS  PubMed  Google Scholar 

  13. Massaro AN, Murthy K, Zaniletti I, Cook N, DiGeronimo R, Dizon ML, et al. Intercenter cost variation for perinatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia. J Pediatr. 2016;173:76–83. e1.

    PubMed  Google Scholar 

  14. Murthy K, Yanowitz TD, DiGeronimo R, Dykes FD, Zaniletti I, Sharma J, et al. Short-term outcomes for preterm infants with surgical necrotizing enterocolitis. J Perinatol. 2014;34:736–40.

    CAS  PubMed  Google Scholar 

  15. Pasquali SK, Jacobs JP, Shook GJ, O’Brien SM, Hall M, Jacobs ML, et al. Linking clinical registry data with administrative data using indirect identifiers: implementation and validation in the congenital heart surgery population. Am Heart J. 2010;160:1099–104.

    PubMed  PubMed Central  Google Scholar 

  16. Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA. 2008;299:2048–55.

    CAS  PubMed  Google Scholar 

  17. Massaro AN, Murthy K, Zaniletti I, Cook N, DiGeronimo R, Dizon M, et al. Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children’s Hospitals Neonatal Consortium HIE focus group. J Perinatol. 2015;35:290–6.

    CAS  PubMed  Google Scholar 

  18. Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–80.

    PubMed  Google Scholar 

  19. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27:21–47.

    PubMed  PubMed Central  Google Scholar 

  20. Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D, et al. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166:1155–64.

    PubMed  Google Scholar 

  21. Puopolo KM, Benitz WE, Zaoutis TE, Committee on Fetus and Newborn, Committee on Infectious Diseases. Management of neonates born at ≥35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142:e20182894. https://doi.org/10.1542/peds.2018-2894.

    PubMed  Google Scholar 

  22. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84.

    CAS  PubMed  Google Scholar 

  23. Hakobyan M, Dijkman KP, Laroche S, Naulaers G, Rijken M, Steiner K, et al. Outcome of infants with therapeutic hypothermia after perinatal asphyxia and early-onset sepsis. Neonatology. 2018;115:127–33.

    PubMed  Google Scholar 

  24. Tann CJ, Nkurunziza P, Nakakeeto M, Oweka J, Kurinczuk JJ, Were J, et al. Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assays. PLoS ONE. 2014;9:e97259.

    PubMed  PubMed Central  Google Scholar 

  25. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003;290:2677–84.

    CAS  PubMed  Google Scholar 

  26. Falck M, Osredkar D, Maes E, Flatebo T, Wood TR, Sabir H, et al. Hypothermic neuronal rescue from infection-sensitised hypoxic-ischaemic brain injury is pathogen dependent. Dev Neurosci. 2017;39:238–47.

    CAS  PubMed  Google Scholar 

  27. Osredkar D, Sabir H, Falck M, Wood T, Maes E, Flatebo T, et al. hypothermia does not reverse cellular responses caused by lipopolysaccharide in neonatal hypoxic-ischaemic brain injury. Dev Neurosci. 2015;37:390–7.

    CAS  PubMed  Google Scholar 

  28. Osredkar D, Thoresen M, Maes E, Flatebo T, Elstad M, Sabir H. Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury. Resuscitation. 2014;85:567–72.

    PubMed  Google Scholar 

  29. Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013. https://doi.org/10.1542/peds.2016-2013.

    PubMed  Google Scholar 

  30. Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173:224–33. https://doi.org/10.1001/jamapediatrics.2018.4826

    PubMed  PubMed Central  Google Scholar 

  31. Tann CJ, Martinello KA, Sadoo S, Lawn JE, Seale AC, Vega-Poblete M, et al. Neonatal encephalopathy with group B streptococcal disease worldwide: systematic review, investigator group datasets, and meta-analysis. Clin Infect Dis. 2017;65(suppl_2):S173–89.

    PubMed  PubMed Central  Google Scholar 

  32. Lakshminrusimha S, Shankaran S, Laptook A, McDonald S, Keszler M, Van Meurs K, et al. Pulmonary hypertension associated with hypoxic-ischemic encephalopathy-antecedent characteristics and comorbidities. J Pediatr. 2018;196:45–51. e3.

    PubMed  PubMed Central  Google Scholar 

  33. Tann CJ, Nakakeeto M, Willey BA, Sewegaba M, Webb EL, Oke I, et al. Perinatal risk factors for neonatal encephalopathy: an unmatched case-control study. Arch Dis Child Fetal Neonatal Ed. 2018;103:F250–6.

    PubMed  Google Scholar 

  34. Schulman J, Dimand RJ, Lee HC, Duenas GV, Bennett MV, Gould JB. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135:826–33.

    PubMed  Google Scholar 

  35. Soll RF, Edwards WH. Antibiotic use in neonatal intensive care. Pediatrics. 2015;135:928–9.

    PubMed  Google Scholar 

  36. Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.

    PubMed  Google Scholar 

  37. Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Stratification of risk of early-onset sepsis in newborns ≥34 weeks’ gestation. Pediatrics. 2014;133:30–6.

    PubMed  PubMed Central  Google Scholar 

  38. Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.

    PubMed  Google Scholar 

  39. Carola D, Vasconcellos M, Sloane A, McElwee D, Edwards C, Greenspan J, et al. Utility of early-onset sepsis risk calculator for neonates born to mothers with chorioamnionitis. J Pediatr. 2018;195:48–52. e1.

    PubMed  Google Scholar 

  40. Jenster M, Bonifacio SL, Ruel T, Rogers EE, Tam EW, Partridge JC, et al. Maternal or neonatal infection: association with neonatal encephalopathy outcomes. Pediatr Res. 2014;76:93–9.

    PubMed  PubMed Central  Google Scholar 

  41. Saito J, Shibasaki J, Shimokaze T, Kishigami M, Ohyama M, Hoshino R, et al. Temporal relationship between serum levels of interleukin-6 and C-reactive protein in therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. Am J Perinatol. 2016;33:1401–6.

    PubMed  Google Scholar 

  42. Chiesa C, Signore F, Assumma M, Buffone E, Tramontozzi P, Osborn JF, et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem. 2001;47:1016–22.

    CAS  PubMed  Google Scholar 

  43. Laxminarayan R, Matsoso P, Pant S, Brower C, Rottingen JA, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168–75.

    PubMed  Google Scholar 

  44. Hamer DH, Darmstadt GL, Carlin JB, Zaidi AK, Yeboah-Antwi K, Saha SK, et al. Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J. 2015;34:e1–8.

    PubMed  Google Scholar 

  45. Panigrahi P, Chandel DS, Hansen NI, Sharma N, Kandefer S, Parida S, et al. Neonatal sepsis in rural India: timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting. J Perinatol. 2017;37:911–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Cilla A, Arnaez J, Suarez J, Megias G, Cabrerizo M, Garcia-Alix A. Perinatal infection and hypoxic-ischemic encephalopathy: a pilot study. J Matern Fetal Neonatal Med. 2016;29:140–2.

    CAS  PubMed  Google Scholar 

  47. Jenster M, Bonifacio SL, Ruel T, Rogers EE, Tam EW, Partridge JC, et al. Maternal or neonatal infection: association with neonatal encephalopathy outcomes. Pediatr Res. 2014;76:93.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are indebted to the following institutions that serve the infants and their families; these institutions have also invested in, and continue to participate in the CHND. The site sponsors/contributors for the CHND are also included:

1. Children’s Healthcare of Atlanta, Atlanta, GA (Francine Dykes, Anthony Piazza)

2. Children’s Healthcare of Atlanta at Scottish Rite (Gregory Sysyn)

3. Children’s Hospital of Alabama, Birmingham, AL (Carl Coghill, Allison Black)

4. Le Bonheur Children’s Hospital, Memphis, TN (Ramasubbareddy Dhanireddy)

5. Children’s Hospital Boston, Boston, MA (Anne Hansen, Tanzeema Houssain)

6. Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL (Karna Murthy, Gustave Falciglia)

7. Cincinnati Children’s Hospital, Cincinnati, OH (Beth Haberman, Breda Poindexter, Amy Nathan, Kristin Nelson, Paul Kingma, Stefanie Riddle, Stephanie Merhar, Heather Kaplan)

8. Nationwide Children’s Hospital, Columbus, OH (Kristina Reber)

9. Children’s Medical Center, Dallas, TX (Rashmin Savani, Luc Brion, Noorjahan Ali)

10. Children’s Hospital Colorado, Aurora, CO (Theresa Grover)

11. Children’s Hospital of Michigan, Detroit, MI (Girija Natarajan)

12. Cook Children’s Health Care System, Fort Worth, TX (Jonathan Nedrelow, Annie Chi, Yvette Johnson)

13. Texas Children’s Hospital, Houston, TX (Gautham Suresh)

14. Riley Children’s Hospital, Indianapolis, IN (William Engle, Lora Simpson, Gregory Sokol)

15. Children’s Mercy Hospitals & Clinics, Kansas City, MO (Eugenia Pallotto)

16. Arkansas Children’s Hospital, Little Rock, AR (Robert Lyle, Becky Rogers)

17. Children’s Hospital Los Angeles, Los Angeles, CA (Lisa Kelly [deceased], Steven Chin, Rachel Chapman)

18. American Family Children’s Hospital, Madison, WI (Jamie Limjoco, Lori Haack)

19. Children’s Hospital & Research Center Oakland, Oakland, CA (David Durand, Jeanette Asselin, Art D’Harlingue, Priscilla Joe)

20. The Children’s Hospital of Philadelphia, Philadelphia, PA (Jacquelyn Evans, Michael Padula, David Munson)

21. St. Christopher’s Hospital for Children, Philadelphia, PA (Suzanne Touch)

22. Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA (Beverly Brozanski)

23. St. Louis Children’s Hospital, St Louis, MO (Tasnim Najaf, Rakesh Rao, Amit Mathur)

24. All Children’s Hospital, St. Petersburg, FL (Victor McKay)

25. Rady Children’s Hospital, San Diego, CA (Mark Speziale, Brian Lane, Laural Moyer)

26. Children’s National Medical Center, Washington, DC (Billie Short)

27. AI DuPont Hospital for Children, Wilmington, DE (Kevin Sullivan)

28. Primary Children’s Medical Center, Salt Lake City, UT (Con Yee Ling)

29. Children’s Hospital of Wisconsin, Milwaukee, WI (Michael Uhing, Ankur Datta)

30. Children’s Hospital of Omaha (Lynne Willett, Nicole Birge)

31. Florida Hospital for Children (Rajan Wadhawan)

32. Seattle Children’s Hospital, Seattle, WA (Elizabeth Jacobsen-Misbe, Robert DiGeronimo, Zeenia Billimoria)

33. Hospital for Sick Children, Toronto, ON (Kyong-Soon Lee)

34. Children’s Hospital Orange County, Los Angeles, CA (Michel Mikhael, Irfan Ahmad)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rakesh Rao.

Ethics declarations

Conflict of interest

IZ is an employee of Children’s Hospitals Association, Inc, (Overland Park, KS). KM is a Board member of the Children’s Hospital National Consortium (CHNC, Kansas City, MO). All other authors have no financial disclosures relevant to this article to disclose. KM is a Board member of the Children’s Hospital National Consortium (CHNC, Kansas City, MO). All other authors have no conflicts of interest relevant to this article to disclose.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Data presented in the manuscript were presented partially (abstract) at the Pediatric Academic Societies meeting in Toronto, Canada, in May 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rao, R., Lee, KS., Zaniletti, I. et al. Antimicrobial therapy utilization in neonates with hypoxic-ischemic encephalopathy (HIE): a report from the Children’s Hospital Neonatal Database (CHND). J Perinatol 40, 70–78 (2020). https://doi.org/10.1038/s41372-019-0527-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0527-2

This article is cited by

Search

Quick links